MA44065A - Composés sulfonamides de dihydroquinoline d'alkyle - Google Patents

Composés sulfonamides de dihydroquinoline d'alkyle

Info

Publication number
MA44065A
MA44065A MA044065A MA44065A MA44065A MA 44065 A MA44065 A MA 44065A MA 044065 A MA044065 A MA 044065A MA 44065 A MA44065 A MA 44065A MA 44065 A MA44065 A MA 44065A
Authority
MA
Morocco
Prior art keywords
dihydroquinoline
alkyl
sulphonamide compounds
sulphonamide
compounds
Prior art date
Application number
MA044065A
Other languages
English (en)
Inventor
Thomas Dineen
Isaac E Marx
Benjamin C Milgram
Matthew Weiss
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MA44065A publication Critical patent/MA44065A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA044065A 2015-12-18 2016-12-19 Composés sulfonamides de dihydroquinoline d'alkyle MA44065A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562269518P 2015-12-18 2015-12-18

Publications (1)

Publication Number Publication Date
MA44065A true MA44065A (fr) 2021-05-26

Family

ID=57758767

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044065A MA44065A (fr) 2015-12-18 2016-12-19 Composés sulfonamides de dihydroquinoline d'alkyle

Country Status (23)

Country Link
US (2) US10383866B2 (fr)
EP (1) EP3390392B1 (fr)
JP (1) JP6903663B2 (fr)
KR (1) KR102804113B1 (fr)
CN (2) CN119119017A (fr)
AU (1) AU2016369652B2 (fr)
CA (1) CA3008484C (fr)
CL (1) CL2018001631A1 (fr)
CO (1) CO2018007436A2 (fr)
CR (1) CR20180368A (fr)
EA (1) EA038286B1 (fr)
IL (1) IL259918B (fr)
MA (1) MA44065A (fr)
MX (1) MX377032B (fr)
MY (1) MY197595A (fr)
NZ (1) NZ743377A (fr)
PE (1) PE20181328A1 (fr)
PH (1) PH12018501285A1 (fr)
SG (1) SG11201805066RA (fr)
TN (1) TN2018000214A1 (fr)
UA (1) UA122913C2 (fr)
WO (1) WO2017106871A1 (fr)
ZA (1) ZA201804033B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身tgr5促效劑之經取代之4-苯基吡啶化合物
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
JP7739051B2 (ja) * 2020-06-10 2025-09-16 アムジエン・インコーポレーテツド シクロブチルジヒドロキノリンスルホンアミド化合物
JP7879815B2 (ja) * 2020-06-10 2026-06-24 アムジエン・インコーポレーテツド ヘテロアルキルジヒドロキノリンスルホンアミド化合物
JP7880201B2 (ja) * 2020-06-10 2026-06-25 アムジエン・インコーポレーテツド シクロプロピルジヒドロキノリンスルホンアミド化合物
EP4385978A4 (fr) * 2021-08-12 2025-08-13 Tyk Medicines Inc Composé polycyclique et son utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
WO2010045197A1 (fr) 2008-10-17 2010-04-22 Xenon Pharmaceuticals, Inc. Composés spiro-oxindole et leur utilisation comme agents thérapeutiques
AU2012296529A1 (en) * 2011-08-17 2014-02-20 Amgen Inc. Heteroaryl sodium channel inhibitors
WO2013086229A1 (fr) * 2011-12-07 2013-06-13 Amgen Inc. Inhibiteurs aryle et hétéroaryle bicycliques des canaux calciques
US9051311B2 (en) 2012-03-09 2015-06-09 Amgen Inc. Sulfamide sodium channel inhibitors
US9212182B2 (en) * 2013-06-12 2015-12-15 Amgen Inc. Bicyclic sulfonamide compounds as sodium channel inhibitors

Also Published As

Publication number Publication date
JP6903663B2 (ja) 2021-07-14
UA122913C2 (uk) 2021-01-20
ZA201804033B (en) 2019-04-24
EP3390392B1 (fr) 2021-10-06
PH12018501285A1 (en) 2019-02-04
TN2018000214A1 (en) 2019-10-04
MX377032B (es) 2025-03-07
EA038286B1 (ru) 2021-08-04
CR20180368A (es) 2018-09-28
CN119119017A (zh) 2024-12-13
IL259918A (en) 2018-07-31
JP2019504016A (ja) 2019-02-14
MY197595A (en) 2023-06-27
AU2016369652B2 (en) 2020-10-22
CL2018001631A1 (es) 2018-09-28
WO2017106871A1 (fr) 2017-06-22
US20200009129A1 (en) 2020-01-09
US20180369227A1 (en) 2018-12-27
EA201891319A1 (ru) 2018-11-30
AU2016369652A1 (en) 2018-06-28
KR102804113B1 (ko) 2025-05-09
CA3008484C (fr) 2023-10-17
BR112018012298A2 (pt) 2018-12-04
IL259918B (en) 2020-06-30
MX2018007432A (es) 2018-09-21
NZ743377A (en) 2022-05-27
PE20181328A1 (es) 2018-08-20
CN108602804B (zh) 2025-05-02
SG11201805066RA (en) 2018-07-30
US10383866B2 (en) 2019-08-20
CN108602804A (zh) 2018-09-28
CA3008484A1 (fr) 2017-06-22
CO2018007436A2 (es) 2018-07-19
KR20180094946A (ko) 2018-08-24
EP3390392A1 (fr) 2018-10-24

Similar Documents

Publication Publication Date Title
EP3720430A4 (fr) Composés benzocarbonyle
EP3691623A4 (fr) Composés de benzosulfonyle
HUE057414T2 (hu) Új szulfonamid karboxamid vegyületek
MA45116A (fr) Composés hétérocycliques comme immunomodulateurs
EP3558322A4 (fr) Composés benzyl-amide phosphodiamide antiviraux
EP3532069A4 (fr) Composés aryl-amide phosphodiamide antiviraux
MA50567A (fr) Nouveaux composés de sulfonamide carboxamide
MA49901A (fr) Nouveaux composés de sulfonamide carboxamide
MA49904A (fr) Nouveaux composés de sulfonamide carboxamide
MA46045A (fr) Composés hétérocycliques utilisés comme immunomodulateurs
MA55194A (fr) Composés hétérocycliques en tant qu'immunomodulateurs
MA45669A (fr) Composés hétérocycliques utilisés comme immunomodulateurs
MA44860A (fr) Composés hétérocycliques utilisés comme immunomodulateurs
MA46091A (fr) Composés biaryles utiles en tant qu'immunomodulateurs
MA42990A (fr) Composés utiles en tant qu'immunomodulateurs
MA47576A (fr) Composés inhibiteurs d'oga bicyclique
MA52119A (fr) Composés hétérocycliques utilisés comme immunomodulateurs
EP3464275A4 (fr) Composés inhibiteurs de l'egfr
MA41614A (fr) Composés antiviraux
EP3551176A4 (fr) Composés hétérocycliques antidiabétiques
MA47420A (fr) Composés inhibiteurs d'oga
MA45148A (fr) Composés de carfilzomib pégylés
EP3311923A4 (fr) Séparateur d'huile
LT3426226T (lt) Oftalmologinė kompozicija
EP3464336A4 (fr) Composés